Literature DB >> 34291377

COVID-19 in the California State Prison System: an Observational Study of Decarceration, Ongoing Risks, and Risk Factors.

Elizabeth T Chin1, Theresa Ryckman2, Lea Prince2, David Leidner3, Fernando Alarid-Escudero4, Jason R Andrews5, Joshua A Salomon2, David M Studdert2,6, Jeremy D Goldhaber-Fiebert7.   

Abstract

BACKGROUND: Correctional institutions nationwide are seeking to mitigate COVID-19-related risks.
OBJECTIVE: To quantify changes to California's prison population since the pandemic began and identify risk factors for COVID-19 infection.
DESIGN: For California state prisons (March 1-October 10, 2020), we described residents' demographic characteristics, health status, COVID-19 risk scores, room occupancy, and labor participation. We used Cox proportional hazard models to estimate the association between rates of COVID-19 infection and room occupancy and out-of-room labor, respectively. PARTICIPANTS: Residents of California state prisons. MAIN MEASURES: Changes in the incarcerated population's size, composition, housing, and activities. For the risk factor analysis, the exposure variables were room type (cells vs. dormitories) and labor participation (any room occupant participating in the prior 2 weeks) and the outcome variable was incident COVID-19 case rates. KEY
RESULTS: The incarcerated population decreased 19.1% (119,401 to 96,623) during the study period. On October 10, 2020, 11.5% of residents were aged ≥60, 18.3% had high COVID-19 risk scores, 31.0% participated in out-of-room labor, and 14.8% lived in rooms with ≥10 occupants. Nearly 40% of residents with high COVID-19 risk scores lived in dormitories. In 9 prisons with major outbreaks (6,928 rooms; 21,750 residents), dormitory residents had higher infection rates than cell residents (adjusted hazard ratio [AHR], 2.51 95% CI, 2.25-2.80) and residents of rooms with labor participation had higher rates than residents of other rooms (AHR, 1.56; 95% CI, 1.39-1.74).
CONCLUSION: Despite reductions in room occupancy and mixing, California prisons still house many medically vulnerable residents in risky settings. Reducing risks further requires a combination of strategies, including rehousing, decarceration, and vaccination.
© 2021. Society of General Internal Medicine.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; exposures; incarcerated populations; infections; prisons

Year:  2021        PMID: 34291377      PMCID: PMC8294831          DOI: 10.1007/s11606-021-07022-x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


INTRODUCTION

Over 380,000 incarcerated people in the USA were diagnosed with severe acute respiratory syndrome coronavirus 2 through February 2021, and approximately 2,300 died (1). Prisons are vulnerable to rapid viral spread, given their population density and the infeasibility of standard distancing measures (2–8). COVID-19-related health outcomes appear worse among incarcerated people than in the general population (3, 9, 10). Correctional systems face difficult trade-offs in their attempts to control COVID-19 transmission. Early releases reduce crowding but may cause public unrest (11). Curtailing in-prison activities (e.g., work or group therapy) limits mixing but is disruptive and may have adverse health effects (12, 13). The federal government has issued guidance (14, 15) on measures to reduce COVID-19 transmission in correctional settings, but the recommendations lack specificity and evidence of efficacy. The evidence base in this area remains extremely limited. The California Department of Corrections and Rehabilitation (CDCR) manages the country’s second largest prison system, with 35 institutions that housed ~120,000 residents in early 2020. CDCR has undertaken multiple interventions to prevent and contain COVID-19 outbreaks. This study describes how CDCR’s incarcerated population has changed during the pandemic, focusing on room occupancy and participation in out-of-room activities. For prisons that have experienced outbreaks, we estimate the extent to which those two factors are associated with COVID-19 infection rates.

METHODS

IRB Approval

Stanford’s institutional review board granted approval (IRB-55835).

Data and Variables

CDCR provided data on all incarcerated people aged ≥18 years residing in its prisons during the period March 1 through October 10, 2020. The data were provided at the person-day-level, which allowed daily tracking of changes in any time-varying information until residents’ release or death. The data included variables indicating residents’ demographic (sex, age, and race or ethnicity) and health characteristics; location; participation in prison labor, education, and other activities; and COVID-19 testing history. The data contained each resident’s security level (1 [lowest] to 4 [highest]) which determines housing locations and eligibility for work and other activities (16). Locational information specified the room in which each resident spent the night. Rooms were defined as discrete spaces, at least partially enclosed by solid walls, and were classified as cells or dormitories of varying sizes. The health information included indicators for diagnosed medical conditions and COVID-19 risk score. This score, developed by CDCR, is an integer-based estimate of each resident’s probability of severe health outcomes following COVID-19 infection. Scores correspond to the presence of demographic and clinical characteristics identified in the literature as risk factors for severe COVID-19-related illness, and CDCR considers scores ≥3 to indicate high-risk (Table S1). Testing information included dates and results. CDCR has been testing residents using real-time PCR and antigen tests since April 2020. Testing expanded during the study period, eventually employing both reactive mass testing and periodic surveillance testing. Prisons experiencing large outbreaks tested residents at particularly high rates (Figure S1). By Fall 2020, all prisons were testing 5–25% of residents every 2 weeks. We created variables to describe risk factors for COVID-19 exposure and transmission, based on residents’ housing situation and their participation in out-of-room activities. With respect to housing, we calculated the daily number of residents housed in each room (square footage of rooms was unavailable). This count variable had a bimodal distribution, with many residents living alone or with one other resident, or in substantially larger rooms (≥10 residents), and relatively few in between. For some analyses, we dichotomized this variable, distinguishing residents in “cells” (1–2 occupants) and “dormitories” (≥3 occupants); this aligned with CDCR’s conception of the major division in room sizes. With respect to activities, the resident-day-level data included information on residents’ out-of-room participation in labor (e.g., janitorial), education (e.g., high school classes), and other activities (e.g., religious services) (17, 18). From April 2020, educational activities were confined to residents’ rooms. Consequently, we focused on labor and other out-of-room non-educational activities excluding recreation and meals which were not comprehensively tracked. We specified variables indicating whether each resident participated in each activity type and variables indicating whether each resident or a roommate did so in the previous 2 weeks. Finally, we classified prisons into 5 categories based on the predominant resident security levels, housing configurations, and CDCR advice: reception centers, medical prisons, low security and general population prisons, high security prisons, and mixed security and medium security prisons (details provided in Table S2).

Analysis

We calculated changes over the study period in the size and composition of the incarcerated population, in housing, and in participation in out-of-room activities (samples for each analysis shown in Figure S2). We used person-level survival analysis to estimate the association between room occupancy and labor activities, respectively, and rates of COVID-19 infection. We focused on sustained within-prison transmission, therefore limiting the analysis to prisons with outbreaks involving substantial resident-to-resident spread. We defined prisons with outbreaks as those having ≥50 cumulative cases during the study period and ≥10 incident cases detected on at least one day in that period. We defined an outbreak’s start date as 14 days prior to the first day with ≥10 incident cases. We specified several additional prison-level and resident-level eligibility criteria for the survival analysis (Figure S3). Briefly, to allow ≥90 days follow-up, we excluded prisons (n=7) with outbreaks that began after July 12, 2020; to minimize confounding, we excluded one prison with testing rates that differed substantially between cells and dormitories; and we excluded prisons (n=3) whose outbreaks were seeded by mass introduction of cases (e.g., San Quentin), because their epidemic growth may have been atypical. Within eligible prisons, we included residents present on the day the outbreak began who were tested for COVID-19 at least once during the 90-day period. The observation period for eligible residents’ observation ran from the start of their prison’s outbreak until the sample collection date of their first positive test or their last negative test. Release or transfer to another prison were also censoring events. We fit a multivariable Cox proportional hazard regression model to estimate the associations of interest. The outcome variable indicated the sample collection date for the first positive COVID-19 test result among residents who had a positive test. The main exposure variables were room occupancy at the outbreak start and room-level labor participation during the 14-day period prior to the outbreak start. We also included prison fixed effects. We assessed the appropriateness of the proportional hazards assumption by inspecting plots of Schoenfeld residuals. We conducted sensitivity analyses. Because there may be systematic differences in how residents with higher COVID-19 risk scores or higher security levels mix with other residents, we added baseline values of these covariates. We varied the required follow-up period for prison inclusion. We allowed the observation period for residents who did not test positive, exit the prison, or die to extend to the end of the study period, regardless of their last negative test date. We estimated the model clustering standard errors at the room and prison levels.

Role of the Funding Sources

This research was supported by the Horowitz Family Foundation, the National Institute on Drug Abuse (R37-DA15612), the National Science Foundation (DGE-1656518), and the Open Society Foundations. The funders had no role in the study’s design, conduct, or reporting, or in the publication decision.

RESULTS

From March 1 to October 10, 2020, the resident population of California prisons decreased from 119,401 to 96,623 (Figure 1), a reduction of 19.1% that reversed prior trends (19). High security prisons (7.0%) and medical prisons (14.4%) had the smallest relative reductions.
Figure 1

CDCR incarcerated population size and average room occupancy over time: Graph shows the change in total prison population size (left) and change in the average number of roommates an individual in that prison has (right), for each of the 35 prisons, color-coded by prison type, and for all prisons combined in black (only right panel), from March 1, 2020 (filled circle), to October 10, 2020 (vertical bar). The outbreak prisons used in the multivariate risk analysis are shown above the dashed line, and remaining prisons are shown below the dashed line.

CDCR incarcerated population size and average room occupancy over time: Graph shows the change in total prison population size (left) and change in the average number of roommates an individual in that prison has (right), for each of the 35 prisons, color-coded by prison type, and for all prisons combined in black (only right panel), from March 1, 2020 (filled circle), to October 10, 2020 (vertical bar). The outbreak prisons used in the multivariate risk analysis are shown above the dashed line, and remaining prisons are shown below the dashed line. On October 10, 2020, 96.7% of residents were male and 11.5% were aged 60 years or older (Table 1). Nearly three-quarters were Hispanic (44.5%) or non-Hispanic Black (29.5%). Forty percent had at least one medical condition, and 18.3% had a COVID-19 risk score of ≥3. The average number of residents per room decreased from 20 to 10. However, seven prisons still averaged ≥20 occupants per room in October 2020, and 25 had ≥1 room with ≥20 occupants (Figures S4-S5). The proportion of residents in dormitories decreased from 37.1 to 30.9%, though a substantial fraction of higher risk residents were still housed in dormitories (Figure S6).
Table 1.

Characteristics of California State Prison Population on October 10, 2020

March 1, 2020 (n=119,401)October 10, 2020 (n=96,623)
Demographic characteristics
Age, mean (SD)41.3 (12.9)41.9 (13.1)
18–2924350 (20.4%)18909 (19.6%)
30–3936573 (30.6%)28618 (29.6%)
40–4926577 (22.3%)21598 (22.4%)
50–5919278 (16.1%)16434 (17.0%)
60–699777 (8.2%)8561 (8.9%)
70–792470 (2.1%)2176 (2.3%)
80+376 (0.3%)327 (0.3%)
Sex
Female4796 (4.0%)3205 (3.3%)
Male114605 (96.0%)93418 (96.7%)
Race
Black33921 (28.4%)28471 (29.5%)
Hispanic52987 (44.4%)42998 (44.5%)
White24615 (20.6%)18623 (19.3%)
Other/unknown7878 (6.6%)6531 (6.8%)
Security level
112466 (10.4%)7340 (7.6%)
252625 (44.1%)45234 (46.8%)
321100 (17.7%)16595 (17.2%)
429661 (24.8%)27088 (28.0%)
Number of roommates, mean (SD)18.9 (38.0)9.3 (22.1)
Cells71573 (59.9%)66626 (69.0%)
Dorms44331 (37.1%)29824 (30.9%)
Work
Worked previous 2 weeks41947 (35.7%)29938 (31.3%)
Clinical
COVID-19 risk score, mean (SD)1.4 (2.0)1.5 (2.0)
COVID-19 risk score of 3+19820 (16.6%)17707 (18.3%)
Pre-existing conditions
Any pre-existing condition*44313 (37.1%)38518 (39.9%)
Advanced liver disease4237 (3.5%)3262 (3.4%)
Asthma14556 (12.2%)12385 (12.8%)
Cancer3027 (2.5%)2706 (2.8%)
COPD3074 (2.6%)2706 (2.8%)
CVD5454 (4.6%)4413 (4.6%)
Diabetes8566 (7.2%)7548 (7.8%)
HIV956 (0.8%)724 (0.7%)
Hypertension25710 (21.5%)23324 (24.1%)
Immunocompromised1377 (1.2%)1235 (1.3%)
Body mass index, mean (SD)28.7 (5.4)28.9 (5.5)
Body mass index > 403942 (3.3%)3523 (3.6%)
COVID-19 testing and cases (cumulative persons since January 1, 2020)
Individuals tested96440
Ages 18–4968981
Ages 50–6924773
Ages 70+2686
Positive (% of tested)15162 (15.7%)
Ages 18–499593 (13.9%)
Ages 50–695012 (20.2%)
Ages 70+557 (20.7%)
Resolved positive (% of Tested)13636 (14.1%)
Ages 18–498524 (12.4%)
Ages 50–694593 (18.5%)
Ages 70+519 (19.3%)
Hospitalized (% of resolved)442 (3.2%)
Ages 18–4999 (1.2%)
Ages 50–69246 (5.4%)
Ages 70+97 (18.7%)
ICU (% of resolved)37 (0.3%)
Ages 18–494 (<0.1%)
Ages 50–6925 (0.5%)
Ages 70+8 (1.5%)
Deaths (% of resolved)68 (0.5%)
Ages 18–497 (0.1%)
Ages 50–6938 (0.8%)
Ages 70+23 (4.4%)

COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; HIV, human immunodeficiency virus; ICU, intensive care unit; SD, standard deviation. See Figure S2 for details on the inclusion criteria in this table. See Table S3 for data on COVID-19 testing and cases stratified by COVID-19 risk score. See Table S4 for information stratified by prison type. *See Table S1 for definitions of the pre-existing conditions included here.

Characteristics of California State Prison Population on October 10, 2020 COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; HIV, human immunodeficiency virus; ICU, intensive care unit; SD, standard deviation. See Figure S2 for details on the inclusion criteria in this table. See Table S3 for data on COVID-19 testing and cases stratified by COVID-19 risk score. See Table S4 for information stratified by prison type. *See Table S1 for definitions of the pre-existing conditions included here. By October 10, 81.8% (79,046) of still-incarcerated individuals had been tested for COVID-19 at least once, and a total of 96,440 residents including those released between March and October had been tested. Of the 96,440 residents, 15,162 were positive; 13,636 of these cases resolved by October 10—3.2% were hospitalized, 0.3% were in intensive care units, and 0.5% died. Severe COVID-19 outcomes were most likely for older and higher risk residents (Table 1, Table S3). Participation in out-of-room activities other than labor decreased precipitously between March and April 2020 and remained low through October. However, labor participation decreased only slightly during the study period (Figure 2). The lowest levels of and the largest decreases in labor participation were among residents aged ≥80 years, but more than 10% of residents in this age group and more than 20% of 70–79-year-olds were still participating in labor in October. These labor participation results were generally consistent according to resident risk measures, prison types, and outbreak history (Tables S4-S5).
Figure 2

Biweekly participation in labor and other out-of-room activities by age: Graph shows rolling average participation in activities, defined as whether an individual participated in labor or other activities with at least one other person during any day in the past 2 weeks. Panels show (A) labor participation by age and (B) other participation by age. Data cover all prisons from March 1, 2020, through October 10, 2020.

Biweekly participation in labor and other out-of-room activities by age: Graph shows rolling average participation in activities, defined as whether an individual participated in labor or other activities with at least one other person during any day in the past 2 weeks. Panels show (A) labor participation by age and (B) other participation by age. Data cover all prisons from March 1, 2020, through October 10, 2020. In the nine prisons with outbreaks that met our eligibility criteria for the multivariable risk analysis, 21,750 eligible residents living in 6,928 rooms were tested at least once. Over 90 days, the cumulative percentage of each prison’s population tested ranged from 21.3 to 99.9%, and the cumulative percentage of each prison’s population confirmed positive ranged from 2.4 to 45.1% (Figures S7-S8). Rates of COVID-19 infection among residents of dormitories (≥3 occupants) were more than double those among residents of cells (adjusted hazard ratio [AHR], 2.51; 95% confidence interval [CI], 2.25–2.80; p<0.001) (Figure 3, Table S6). Residents of rooms with occupants participating in out-of-room labor also had higher rates of infection compared to those without participation (AHR, 1.56; 95% CI, 1.39–1.74). These differences represent a cumulative risk of infection that is 28.6 percentage points higher (95% CI, 16.7–30.6%; 62.1% vs. 33.4%) for dormitories compared to cells, and 13.1 percentage points higher (95% CI, 12.8–13.3%; 53.7% vs. 40.6%) for rooms with labor participation than for rooms without it. Estimates proved fairly robust in sensitivity analyses (Tables S6-S8; Figure S9). While, in theory, residents with higher COVID-19 risk scores may take greater precautions to avoid more severe consequences from infection, analyses that included this variable did not detect an association with lower risks.
Figure 3

Adjusted cumulative risk of infection in outbreak prisons: Graphs show the adjusted marginal cumulative risk of infection over 90 days from the start of a prison outbreak for (A) room type and (B) room labor (i.e., whether anyone in the room participated in out-of-room labor). Data includes 90 days follow-up for 9 prisons.

Adjusted cumulative risk of infection in outbreak prisons: Graphs show the adjusted marginal cumulative risk of infection over 90 days from the start of a prison outbreak for (A) room type and (B) room labor (i.e., whether anyone in the room participated in out-of-room labor). Data includes 90 days follow-up for 9 prisons.

DISCUSSION

Over a 7-month period following the onset of the COVID-19 pandemic, the resident population of California state prisons decreased by one-fifth and room occupancy halved. However, many medically vulnerable residents remained incarcerated, and a substantial proportion of them continued to live in dormitory housing and participate in work activities that involved mixing. In nine prisons that experienced large outbreaks, we found that residents living in rooms with ≥2 others had a 2.5-fold higher infection rate and that residents in a room whose occupants participated in out-of-room work had a 1.6-fold higher rate. Since the pandemic began, CDCR has taken drastic steps to mitigate transmission and stem outbreaks. Nonetheless, as of February 13, 2021, there had been 48,758 confirmed cases among residents and 205 deaths. These represent substantially higher rates of infection and mortality that state’s general population has experienced. The patterns we observed suggest opportunities for further risk reduction. The substantial numbers of older and higher-risk residents who continue to live in high occupancy rooms is an important target group for prevention efforts. Members of those high-risk groups who participate in group activities, or who share a room with others who do, are also an important target group. Our results are consistent with key messages from the limited evidence base on respiratory infections in incarcerated populations (2–13, 20–22). The interconnected nature of the residents of congregate institutions means that outbreaks, especially those that penetrate higher occupancy rooms, can quickly become building or prison outbreaks. Correctional facilities, nationally and internationally, should redouble efforts not only to prevent outbreaks but also to increase protective measures taken for their large, medically vulnerable subpopulations, including further reductions in the density of living arrangements (23). Our access to person-level, daily data from a large prison system with high rates of testing created analytical opportunities that recent studies of COVID-19 in incarcerated populations have not had, including minimizing biases from selection into testing. However, our study also had limitations. First, we could not identify networks of specific contacts, a limitation that is likely to have mattered most to our estimates of the effect of labor participation. Second, we used room occupancy to indicate in-room contacts because density measures (e.g., residents per square foot) were not available. The most plausible effect of misclassifying room exposures would be to bias to the null our estimates of the effect of living in higher occupancy rooms. Third, we lacked information on some potential exposures, such as contacts with staff and during meals in common areas. Finally, although CDCR undertook extensive testing, not all residents were tested and test frequency varied across institutions. If residents of dormitories or of rooms with labor participation were tested relatively frequently, or testing in these rooms more precisely targeted infected residents, our estimates of these factors on infection risk may be biased upward. Prisons remain particularly dangerous settings for COVID-19-related morbidity and mortality. Our study shows that thousands of vulnerable incarcerated people continue to be housed in settings where their risk of COVID-19 infection is high. Protective measures such as decarceration, testing, vaccination, and efforts to enhance vaccine uptake remain vital (24,25). Residents at greatest risk of transmission and infection, such as those living dormitories and participating in labor, should be prioritized. Furthermore, as correctional systems offer vaccination to residents, our study highlights the importance of prioritizing both those at highest risk of adverse outcomes following infection and those most likely to contract and spread the virus. (PDF 1796 kb)
  17 in total

1.  COVID-19, Decarceration, and the Role of Clinicians, Health Systems, and Payers: A Report From the National Academy of Sciences, Engineering, and Medicine.

Authors:  Emily A Wang; Bruce Western; Donald M Berwick
Journal:  JAMA       Date:  2020-12-08       Impact factor: 56.272

2.  Early Effects of COVID-19 on Programs Providing Medications for Opioid Use Disorder in Jails and Prisons.

Authors:  Sachini Bandara; Alene Kennedy-Hendricks; Sydney Merritt; Colleen L Barry; Brendan Saloner
Journal:  J Addict Med       Date:  2020 Sep/Oct       Impact factor: 3.702

3.  Social Distancing and Incarceration: Policy and Management Strategies to Reduce COVID-19 Transmission and Promote Health Equity Through Decarceration.

Authors:  Brandy F Henry
Journal:  Health Educ Behav       Date:  2020-05-10

Review 4.  Medical Isolation and Solitary Confinement: Balancing Health and Humanity in US Jails and Prisons During COVID-19.

Authors:  David H Cloud; Cyrus Ahalt; Dallas Augustine; David Sears; Brie Williams
Journal:  J Gen Intern Med       Date:  2020-07-06       Impact factor: 5.128

5.  Epidemiology of COVID-19 Among Incarcerated Individuals and Staff in Massachusetts Jails and Prisons.

Authors:  Monik C Jiménez; Tori L Cowger; Lisa E Simon; Maya Behn; Nicole Cassarino; Mary T Bassett
Journal:  JAMA Netw Open       Date:  2020-08-03

6.  Evaluating strategies for control of tuberculosis in prisons and prevention of spillover into communities: An observational and modeling study from Brazil.

Authors:  Tarub S Mabud; Maria de Lourdes Delgado Alves; Albert I Ko; Sanjay Basu; Katharine S Walter; Ted Cohen; Barun Mathema; Caroline Colijn; Everton Lemos; Julio Croda; Jason R Andrews
Journal:  PLoS Med       Date:  2019-01-24       Impact factor: 11.069

7.  Risk Factors for SARS-CoV-2 in a Statewide Correctional System.

Authors:  Byron S Kennedy; Robert P Richeson; Amy J Houde
Journal:  N Engl J Med       Date:  2020-11-24       Impact factor: 91.245

8.  Mass Testing for SARS-CoV-2 in 16 Prisons and Jails - Six Jurisdictions, United States, April-May 2020.

Authors:  Liesl M Hagan; Samantha P Williams; Anne C Spaulding; Robin L Toblin; Jessica Figlenski; Jeanne Ocampo; Tara Ross; Heidi Bauer; Justine Hutchinson; Kimberley D Lucas; Matthew Zahn; Chun Chiang; Timothy Collins; Alexis Burakoff; Juli Bettridge; Ginger Stringer; Randolph Maul; Kristen Waters; Courtney Dewart; Jennifer Clayton; Sietske de Fijter; Radha Sadacharan; Linda Garcia; Naomi Lockett; Kirstin Short; Laxman Sunder; Senad Handanagic
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-08-21       Impact factor: 17.586

9.  A Retrospective Analysis and Comparison of Prisoners and Community-Based Patients with COVID-19 Requiring Intensive Care During the First Phase of the Pandemic in West Texas.

Authors:  Kiran Ali; Sanjana Rao; Gilbert Berdine; Victor Test; Kenneth Nugent
Journal:  J Prim Care Community Health       Date:  2020 Jan-Dec

10.  Network Characteristics and Visualization of COVID-19 Outbreak in a Large Detention Facility in the United States - Cook County, Illinois, 2020.

Authors:  Uzay Kırbıyık; Alison M Binder; Isaac Ghinai; Chad Zawitz; Rebecca Levin; Usha Samala; Michelle Bryant Smith; Jane Gubser; Bridgette Jones; Kate Varela; Josh Rafinski; Anne Fitzgerald; Peter Orris; Alex Bahls; Sharon Welbel; Connie Mennella; Stephanie R Black; Paige A Armstrong
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-11-06       Impact factor: 17.586

View more
  13 in total

1.  The impact of COVID-19 vaccination in prisons in England and Wales: a metapopulation model.

Authors:  Mark Jit; Frank Sandmann; Ciara V McCarthy; Oscar O'Mara; Edwin van Leeuwen
Journal:  BMC Public Health       Date:  2022-05-18       Impact factor: 4.135

2.  COVID-19 Preventive Measures in Northern California Jails: Perceived Deficiencies, Barriers, and Unintended Harms.

Authors:  Yiran E Liu; Christopher LeBoa; Marcela Rodriguez; Beruk Sherif; Chrisele Trinidad; Michael Del Rosario; Sophie Allen; Christine Clifford; Jennifer Redding; Wei-Ting Chen; Lisa G Rosas; Carlos Morales; Alexander Chyorny; Jason R Andrews
Journal:  Front Public Health       Date:  2022-06-14

3.  Uptake of COVID-19 Vaccination Among Frontline Workers in California State Prisons.

Authors:  Lea Prince; Elizabeth Long; David M Studdert; David Leidner; Elizabeth T Chin; Jason R Andrews; Joshua A Salomon; Jeremy D Goldhaber-Fiebert
Journal:  JAMA Health Forum       Date:  2022-03-11

4.  The health impacts of the COVID-19 pandemic on adults who experience imprisonment globally: A mixed methods systematic review.

Authors:  Hannah Kim; Emily Hughes; Alice Cavanagh; Emily Norris; Angela Gao; Susan J Bondy; Katherine E McLeod; Tharsan Kanagalingam; Fiona G Kouyoumdjian
Journal:  PLoS One       Date:  2022-05-20       Impact factor: 3.752

5.  Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego-Tijuana border region.

Authors:  Steffanie A Strathdee; Daniela Abramovitz; Alicia Harvey-Vera; Carlos F Vera; Gudelia Rangel; Irina Artamonova; Antoine Chaillon; Caroline Ignacio; Alheli Calderon; Natasha K Martin; Thomas L Patterson
Journal:  PLoS One       Date:  2021-11-22       Impact factor: 3.752

6.  Seroprevalence and Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 Among Incarcerated Adult Men in Quebec, Canada, 2021.

Authors:  Nadine Kronfli; Camille Dussault; Mathieu Maheu-Giroux; Alexandros Halavrezos; Sylvie Chalifoux; Jessica Sherman; Hyejin Park; Lina Del Balso; Matthew P Cheng; Sébastien Poulin; Joseph Cox
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

7.  Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Among Incarcerated People in California State Prisons: Retrospective Cohort Study.

Authors:  Elizabeth T Chin; David Leidner; Yifan Zhang; Elizabeth Long; Lea Prince; Stephanie J Schrag; Jennifer R Verani; Ryan E Wiegand; Fernando Alarid-Escudero; Jeremy D Goldhaber-Fiebert; David M Studdert; Jason R Andrews; Joshua A Salomon
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

Review 8.  The Risk of COVID-19 Infection in Prisons and Prevention Strategies: A Systematic Review and a New Strategic Protocol of Prevention.

Authors:  Massimiliano Esposito; Monica Salerno; Nunzio Di Nunno; Federica Ministeri; Aldo Liberto; Francesco Sessa
Journal:  Healthcare (Basel)       Date:  2022-01-29

9.  COVID-19 Infection Among Incarcerated Individuals and Prison Staff in Lombardy, Italy, March 2020 to February 2021.

Authors:  Sara Mazzilli; Lara Tavoschi; Alessandro Soria; Marco Fornili; Giorgia Cocca; Teresa Sebastiani; Giuditta Scardina; Cristina Cairone; Guglielmo Arzilli; Giuseppe Lapadula; Luca Ceccarelli; Nicola Cocco; Raffaella Bartolotti; Stefano De Vecchi; Giacomo Placidi; Leonardo Rezzonico; Laura Baglietto; Ruggero Giuliani; Roberto Ranieri
Journal:  JAMA Netw Open       Date:  2022-03-01

10.  A study of SARS-COV-2 outbreaks in US federal prisons: the linkage between staff, incarcerated populations, and community transmission.

Authors:  Sherry Towers; Danielle Wallace; Jason Walker; John M Eason; Jake R Nelson; Tony H Grubesic
Journal:  BMC Public Health       Date:  2022-03-11       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.